KKAMG
ABBV icon

Kernodle & Katon Asset Management Group’s AbbVie ABBV Stock Holding History

Kernodle & Katon Asset Management Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$11K Buy
166
+17
+11% +$1.07K 0.01% 219
2016
Q4 		$9K Buy
149
+40
+37% +$2.44K 0.01% 222
2016
Q3 		$7K Buy
109
+20
+22% +$1.29K ﹤0.01% 272
2016
Q2 		$6K Hold
89
– – 0.01% 240
2016
Q1 		$5K Buy
+89
New +$4.96K ﹤0.01% 246

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Kernodle & Katon Asset Management Group's ABBV Position: Q1 2017 in Review

Kernodle & Katon Asset Management Group increased its AbbVie (ABBV) stake by 11% in Q1 2017, buying an estimated $1.07K and bringing the position to 166 shares worth $11K. The position accounts for 0.01% of the portfolio, ranked #219.

Kernodle & Katon Asset Management Group first reported a position in ABBV in Q1 2016 and has held it in 5 quarters since. 1,727 funds tracked by Wall St. Rank hold ABBV as of Q1 2017.

  • Kernodle & Katon Asset Management Group held 166 shares of AbbVie worth $11K as of Q1 2017.
  • Kernodle & Katon Asset Management Group bought 17 AbbVie shares in Q1 2017, an estimated $1.07K.
  • AbbVie made up 0.01% of Kernodle & Katon Asset Management Group's portfolio in Q1 2017, its #219 holding.
  • Kernodle & Katon Asset Management Group first reported a position in AbbVie in Q1 2016 and has held it in 5 quarters since.
  • 1,727 funds tracked by Wall St. Rank held AbbVie as of Q1 2017.

Based on Kernodle & Katon Asset Management Group's 13F filing for Q1 2017, filed 12 May 2017.